Urinary 8-oxoGsn Promising Biomarker for Physiologic Age

Share this content:
Urinary 8-oxoGsn Promising Biomarker for Physiologic Age
Urinary 8-oxoGsn Promising Biomarker for Physiologic Age

WEDNESDAY, Feb. 28, 2018 (HealthDay News) -- 8-oxo-7, 8-dihydroguanosine (8-oxoGsn) is a promising biomarker for physiologic age, corresponding more closely with age than 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodGsn), according to a study published online Feb. 27 in Frontiers in Aging Neuroscience.

For their study, Wei Gan, from Sichuan University in Chengdu, China, and colleagues randomly selected 1,228 healthy Chinese residents age 2 to 90 years. Spot urine samples were obtained and 8-oxodGsn and 8-oxoGsn concentrations were measured.

The researchers found that for both analytes, the calibration curve was linear in the range of 0.2 to 500 ng/mL. The lowest limit of quantification was 0.2 and 0.1 ng/mL for 8-oxodGsn and 8-oxoGsn, respectively. In both genders, there were age-dependent increases in the biomarkers from the 21- to 30-year-old group to the 81- to 90-year-old group. The levels of 8-oxodGsn and 8-oxoGsn in urine were much higher in females than males among those aged older than 61 years of age. Compared with 8-oxodGsn, the content of 8-oxoGsn correlated more closely with age and was higher for a given individual.

"Urinary 8-oxoGsn may be a potential biomarker to determine a person's physiologic age and identify individuals at high risk of developing age-associated disease," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »